These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 8548644)
1. [Comparative study of nicardipine versus placebo in the prevention of cognitive deterioration in patients with transient ischemic attack]. Moltó JM; Falip R; Martín R; Insa R; Pastor I; Matías-Guiu J Rev Neurol; 1995; 23(119):54-8. PubMed ID: 8548644 [TBL] [Abstract][Full Text] [Related]
2. [An experimental, randomized, double-blind, placebo-controlled clinical trial to infestigate the effect of nicardipine on cognitive function in patients with vascular dementia. Spanish group of nicardipine study in vascular dementia]. Rev Neurol; 1999 May 1-15; 28(9):835-45. PubMed ID: 10390744 [TBL] [Abstract][Full Text] [Related]
3. [A study of the tolerability and effectiveness of nicardipine retard in cognitive deterioration of vascular origin]. González-González JA; Lozano R Rev Neurol; 2000 Apr 16-30; 30(8):719-28. PubMed ID: 10893735 [TBL] [Abstract][Full Text] [Related]
4. [A double-blind controlled clinical trial of nicardipine versus placebo in acute cerebral focal ischemia]. Marín Gámez N; Soto Mas JA; Aguilar Martínez JL; Bermúdez García JM; Salim A; Ramos Jiménez A; Gil Extremera B Med Clin (Barc); 1988 Apr; 90(17):690-2. PubMed ID: 3045445 [No Abstract] [Full Text] [Related]
5. Nicardipine use in cerebrovascular disease: a review of controlled clinical studies. Amenta F; Lanari A; Mignini F; Silvestrelli G; Traini E; Tomassoni D J Neurol Sci; 2009 Aug; 283(1-2):219-23. PubMed ID: 19303080 [TBL] [Abstract][Full Text] [Related]
6. [The pathogenesis and the preventive treatment of cerebral vasospasm following subarachnoid hemorrhage--especially clinical and pharmacological effect of Ca++ antagonist for vasospasm]. Nishizawa Y Nihon Rinsho; 1993 Dec; 51 Suppl():389-96. PubMed ID: 8121018 [No Abstract] [Full Text] [Related]
7. Nicardipine in the treatment of outpatients with cerebrovascular disorders. Lozano R; Balaguer A Clin Ther; 1991; 13(4):496-9. PubMed ID: 1934002 [TBL] [Abstract][Full Text] [Related]
9. Intravenous infusion of calcium antagonist, nicardipine, does not increase intracranial pressure: evaluation in a rat model of transient cerebral ischemia and reperfusion. Matsuzaki T; Kano T; Katayama Y; Nakamura S; Harada T Neurol Res; 2008 Jun; 30(5):531-5. PubMed ID: 18241526 [TBL] [Abstract][Full Text] [Related]
10. Clinical trial of nicardipine in treatment of mild to moderate hypertension. Yajnik VH; Vatsaraj DJ; Acharya HK; Yajnik NV J Assoc Physicians India; 1995 Jun; 43(6):401-3. PubMed ID: 8906946 [No Abstract] [Full Text] [Related]
11. Nicardipine improves the antidepressant action of ECT but does not improve cognition. Dubovsky SL; Buzan R; Thomas M; Kassner C; Cullum CM J ECT; 2001 Mar; 17(1):3-10. PubMed ID: 11281512 [TBL] [Abstract][Full Text] [Related]
12. Nicardipine: a hypotensive dihydropyridine-type calcium antagonist with a peculiar cerebrovascular profile. Amenta F; Tomassoni D; Traini E; Mignini F; Veglio F Clin Exp Hypertens; 2008 Nov; 30(8):808-26. PubMed ID: 19021030 [TBL] [Abstract][Full Text] [Related]
13. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)]. Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451 [TBL] [Abstract][Full Text] [Related]
14. Cognitive performance in relation to vitamin status in healthy elderly German women-the effect of 6-month multivitamin supplementation. Wolters M; Hickstein M; Flintermann A; Tewes U; Hahn A Prev Med; 2005 Jul; 41(1):253-9. PubMed ID: 15917019 [TBL] [Abstract][Full Text] [Related]
15. The Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischemic strOke or tRansient ischeMic attack (PERFORM) study: baseline characteristics of the population. Bousser MG; Amarenco P; Chamorro A; Fisher M; Ford I; Fox K; Hennerici M; Mattle HP; Rothwell PM; Cerebrovasc Dis; 2009; 27(6):608-13. PubMed ID: 19407444 [TBL] [Abstract][Full Text] [Related]
16. Effects of intracoronary nicardipine, diltiazem and verapamil on coronary blood flow. Fugit MD; Rubal BJ; Donovan DJ J Invasive Cardiol; 2000 Feb; 12(2):80-5. PubMed ID: 10731269 [TBL] [Abstract][Full Text] [Related]
17. Impact of visual impairment on measures of cognitive function for children with congenital toxoplasmosis: implications for compensatory intervention strategies. Roizen N; Kasza K; Karrison T; Mets M; Noble AG; Boyer K; Swisher C; Meier P; Remington J; Jalbrzikowski J; McLeod R; Kipp M; Rabiah P; Chamot D; Estes R; Cezar S; Mack D; Pfiffner L; Stein M; Danis B; Patel D; Hopkins J; Holfels E; Stein L; Withers S; Cameron A; Perkins J; Heydemann P Pediatrics; 2006 Aug; 118(2):e379-90. PubMed ID: 16864640 [TBL] [Abstract][Full Text] [Related]
18. [Hypertension as a risk factor for cognitive disorders and dementia]. Ito T; Kario K; Shimada K Nihon Rinsho; 2004 Mar; 62 Suppl 3():377-80. PubMed ID: 15171403 [No Abstract] [Full Text] [Related]
19. Amygdala in stroke/transient ischemic attack patients and its relationship to cognitive impairment and psychopathology: the Sydney Stroke Study. Sachdev PS; Chen X; Joscelyne A; Wen W; Brodaty H Am J Geriatr Psychiatry; 2007 Jun; 15(6):487-96. PubMed ID: 17545449 [TBL] [Abstract][Full Text] [Related]